CD9 and Stroke: AEVs derived from reactive astrocytes with anti-inflammatory properties possess CD63 and CD9 tetraspanins and miR-146a-5p, which regulate glial scars by suppressing NF-κB and TNF-α, which permit axonal outgrowth, thereby improving stroke recovery.